Drug
Pegvisomant
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Needle Issue | 201 | 36.3 | 38.1 | signal |
| 2 | Helicobacter Infection | 57 | 28.8 | 29.2 | signal |
| 3 | Injection Site Discomfort | 54 | 26.9 | 27.3 | signal |
| 4 | Neoplasm | 54 | 24.1 | 24.4 | signal |
| 5 | Bladder Disorder | 42 | 21.7 | 21.9 | signal |
| 6 | Brain Neoplasm | 36 | 20.1 | 20.3 | signal |
| 7 | Thyroid Disorder | 53 | 17.7 | 17.9 | signal |
| 8 | Peripheral Coldness | 47 | 17.5 | 17.7 | signal |
| 9 | Poor Quality Product Administered | 34 | 17.1 | 17.2 | signal |
| 10 | Mass | 46 | 16.9 | 17.0 | signal |
| 11 | Gallbladder Disorder | 58 | 16.6 | 16.9 | signal |
| 12 | Blood Pressure Systolic Increased | 62 | 16.3 | 16.5 | signal |
| 13 | Blood Glucose Fluctuation | 33 | 15.4 | 15.5 | signal |
| 14 | Heart Rate Decreased | 103 | 15.0 | 15.4 | signal |
| 15 | Musculoskeletal Discomfort | 47 | 14.0 | 14.2 | signal |
| 16 | Neoplasm Progression | 95 | 13.9 | 14.2 | signal |
| 17 | Bone Disorder | 49 | 13.7 | 13.8 | signal |
| 18 | Cholelithiasis | 87 | 13.6 | 13.9 | signal |
| 19 | Injection Site Mass | 91 | 12.7 | 12.9 | signal |
| 20 | Syringe Issue | 42 | 12.3 | 12.4 | signal |
| 21 | Nocturia | 28 | 11.9 | 11.9 | signal |
| 22 | Sleep Apnoea Syndrome | 42 | 11.3 | 11.4 | signal |
| 23 | Wound Infection | 23 | 10.9 | 10.9 | signal |
| 24 | Glycosylated Haemoglobin Increased | 53 | 10.8 | 10.9 | signal |
| 25 | Full Blood Count Decreased | 42 | 10.7 | 10.8 | signal |
| 26 | Incorrect Route Of Product Administration | 35 | 10.7 | 10.8 | signal |
| 27 | Faeces Discoloured | 45 | 10.7 | 10.8 | signal |
| 28 | Diabetes Mellitus | 147 | 9.9 | 10.2 | signal |
| 29 | Body Temperature Decreased | 19 | 9.8 | 9.9 | signal |
| 30 | Brain Injury | 18 | 9.2 | 9.2 | signal |
| 31 | Jaundice | 48 | 9.1 | 9.2 | signal |
| 32 | Limb Discomfort | 55 | 9.1 | 9.2 | signal |
| 33 | Injection Site Bruising | 139 | 9.0 | 9.3 | signal |
| 34 | Product Dose Omission In Error | 47 | 9.0 | 9.1 | signal |
| 35 | Device Leakage | 72 | 8.7 | 8.9 | signal |
| 36 | Tooth Abscess | 17 | 8.5 | 8.6 | signal |
| 37 | Foot Deformity | 18 | 8.3 | 8.4 | signal |
| 38 | Injection Site Induration | 21 | 8.3 | 8.3 | signal |
| 39 | Hepatic Enzyme Increased | 110 | 8.3 | 8.5 | signal |
| 40 | Urinary Incontinence | 42 | 7.3 | 7.3 | signal |
| 41 | Tendonitis | 22 | 7.3 | 7.3 | signal |
| 42 | Musculoskeletal Pain | 74 | 7.2 | 7.3 | signal |
| 43 | Bone Pain | 82 | 7.2 | 7.3 | signal |
| 44 | Device Defective | 22 | 7.0 | 7.0 | signal |
| 45 | Blood Pressure Increased | 205 | 6.9 | 7.2 | signal |
| 46 | Lung Neoplasm Malignant | 55 | 6.8 | 6.9 | signal |
| 47 | Dysuria | 49 | 6.8 | 6.9 | signal |
| 48 | Blood Glucose Decreased | 64 | 6.8 | 6.9 | signal |
| 49 | Blood Triglycerides Increased | 21 | 6.1 | 6.1 | signal |
| 50 | Feeling Cold | 33 | 6.1 | 6.1 | signal |
| 51 | Eating Disorder | 25 | 6.0 | 6.0 | signal |
| 52 | Stress | 84 | 6.0 | 6.1 | signal |
| 53 | Eructation | 22 | 5.9 | 6.0 | signal |
| 54 | Arthritis | 87 | 5.7 | 5.8 | signal |
| 55 | Blood Iron Decreased | 13 | 5.7 | 5.7 | signal |
| 56 | Product Use Issue | 203 | 5.6 | 5.8 | signal |
| 57 | Sciatica | 17 | 5.5 | 5.5 | signal |
| 58 | Gastroenteritis Viral | 19 | 5.4 | 5.4 | signal |
| 59 | Blood Cholesterol Increased | 48 | 5.3 | 5.3 | signal |
| 60 | Blood Glucose Abnormal | 19 | 5.3 | 5.3 | signal |
| 61 | Blood Test Abnormal | 14 | 5.1 | 5.1 | signal |
| 62 | Liver Function Test Increased | 21 | 5.0 | 5.1 | signal |
| 63 | Iron Deficiency Anaemia | 9 | 5.0 | 5.0 | signal |
| 64 | Product Dispensing Error | 21 | 5.0 | 5.0 | signal |
| 65 | Intentional Dose Omission | 26 | 4.9 | 4.9 | signal |
| 66 | Intentional Product Misuse | 82 | 4.8 | 4.9 | signal |
| 67 | Product Dose Omission Issue | 268 | 4.8 | 5.1 | signal |
| 68 | Hyperhidrosis | 121 | 4.8 | 4.9 | signal |
| 69 | Limb Injury | 25 | 4.7 | 4.8 | signal |
| 70 | Hip Arthroplasty | 14 | 4.7 | 4.7 | signal |
| 71 | Ocular Discomfort | 10 | 4.7 | 4.7 | signal |
| 72 | Therapeutic Product Effect Incomplete | 64 | 4.6 | 4.7 | signal |
| 73 | Abdominal Distension | 92 | 4.5 | 4.6 | signal |
| 74 | Temperature Intolerance | 9 | 4.5 | 4.5 | signal |
| 75 | Cholecystectomy | 10 | 4.5 | 4.5 | signal |
| 76 | Body Temperature Increased | 18 | 4.5 | 4.5 | signal |
| 77 | Illness | 88 | 4.5 | 4.6 | signal |
| 78 | Contusion | 83 | 4.4 | 4.5 | signal |
| 79 | Injection Site Pain | 261 | 4.4 | 4.6 | signal |
| 80 | Injection Site Reaction | 59 | 4.4 | 4.5 | signal |
| 81 | Hepatotoxicity | 19 | 4.4 | 4.4 | signal |
| 82 | Device Breakage | 33 | 4.3 | 4.3 | signal |
| 83 | Adrenal Insufficiency | 10 | 4.3 | 4.3 | signal |
| 84 | Peripheral Swelling | 128 | 4.3 | 4.4 | signal |
| 85 | Bursitis | 10 | 4.2 | 4.3 | signal |
| 86 | Injection Site Haemorrhage | 65 | 4.2 | 4.3 | signal |
| 87 | Product Dose Omission | 53 | 4.1 | 4.1 | signal |
| 88 | Blood Calcium Decreased | 9 | 4.1 | 4.1 | signal |
| 89 | Ear Pain | 15 | 4.0 | 4.0 | signal |
| 90 | Skeletal Injury | 8 | 3.9 | 3.9 | signal |
| 91 | Product Complaint | 19 | 3.9 | 3.9 | signal |
| 92 | Cholecystitis | 9 | 3.9 | 3.9 | signal |
| 93 | Blood Pressure Abnormal | 15 | 3.9 | 3.9 | signal |
| 94 | Blood Sodium Decreased | 14 | 3.8 | 3.8 | signal |
| 95 | Arthralgia | 300 | 3.7 | 3.9 | signal |
| 96 | Prescribed Overdose | 14 | 3.7 | 3.7 | signal |
| 97 | Neoplasm Malignant | 48 | 3.7 | 3.7 | signal |
| 98 | Vitamin D Deficiency | 7 | 3.7 | 3.7 | signal |
| 99 | Blood Urea Increased | 12 | 3.7 | 3.7 | signal |
| 100 | Ligament Sprain | 7 | 3.6 | 3.6 | signal |
| 101 | Blood Pressure Fluctuation | 17 | 3.6 | 3.6 | signal |
| 102 | Drug Resistance | 18 | 3.6 | 3.6 | signal |
| 103 | Nephrolithiasis | 32 | 3.6 | 3.6 | signal |
| 104 | Underdose | 51 | 3.6 | 3.6 | signal |
| 105 | Sluggishness | 7 | 3.5 | 3.5 | signal |
| 106 | Cardiac Failure | 55 | 3.5 | 3.5 | signal |
| 107 | Injection Site Haematoma | 10 | 3.5 | 3.5 | signal |
| 108 | Drug Intolerance | 64 | 3.4 | 3.4 | signal |
| 109 | Neck Pain | 37 | 3.4 | 3.4 | signal |
| 110 | Incontinence | 7 | 3.4 | 3.4 | signal |
| 111 | Glomerular Filtration Rate Decreased | 8 | 3.4 | 3.4 | signal |
| 112 | Body Height Decreased | 7 | 3.3 | 3.3 | signal |
| 113 | Product Packaging Issue | 6 | 3.3 | 3.3 | signal |
| 114 | Cardiomegaly | 8 | 3.3 | 3.3 | signal |
| 115 | Blood Alkaline Phosphatase Increased | 16 | 3.3 | 3.3 | signal |
| 116 | Headache | 402 | 3.3 | 3.5 | signal |
| 117 | Gait Disturbance | 123 | 3.3 | 3.4 | signal |
| 118 | Bradycardia | 34 | 3.3 | 3.3 | signal |
| 119 | Blood Glucose Increased | 121 | 3.3 | 3.3 | signal |
| 120 | Injection Site Nodule | 7 | 3.3 | 3.3 | signal |
| 121 | Flatulence | 36 | 3.3 | 3.3 | signal |
| 122 | Eye Inflammation | 6 | 3.3 | 3.3 | signal |
| 123 | Device Use Issue | 11 | 3.3 | 3.3 | signal |
| 124 | Wrong Technique In Device Usage Process | 29 | 3.3 | 3.3 | signal |
| 125 | Drug Dose Omission By Device | 48 | 3.2 | 3.2 | signal |
| 126 | Laboratory Test Abnormal | 18 | 3.1 | 3.1 | signal |
| 127 | Incorrect Product Storage | 8 | 3.1 | 3.1 | signal |
| 128 | Atrial Fibrillation | 58 | 3.0 | 3.1 | signal |
| 129 | Haemorrhage | 62 | 3.0 | 3.1 | signal |
| 130 | Muscular Weakness | 67 | 3.0 | 3.1 | signal |
| 131 | Joint Swelling | 71 | 3.0 | 3.1 | signal |
| 132 | Back Pain | 137 | 3.0 | 3.1 | signal |
| 133 | Hyperglycaemia | 21 | 3.0 | 3.0 | signal |
| 134 | Haemoglobin Decreased | 59 | 2.9 | 3.0 | signal |
| 135 | Influenza | 64 | 2.9 | 3.0 | signal |
| 136 | Libido Decreased | 7 | 2.9 | 2.9 | signal |
| 137 | Diabetes Mellitus Inadequate Control | 10 | 2.9 | 2.9 | signal |
| 138 | Injection Site Discolouration | 7 | 2.9 | 2.9 | signal |
| 139 | Off Label Use | 489 | 2.9 | 3.1 | signal |
| 140 | Type 2 Diabetes Mellitus | 19 | 2.9 | 2.9 | signal |
| 141 | Abdominal Discomfort | 94 | 2.9 | 2.9 | signal |
| 142 | Joint Injury | 12 | 2.9 | 2.9 | signal |
| 143 | Subdural Haematoma | 8 | 2.9 | 2.9 | signal |
| 144 | Paralysis | 8 | 2.9 | 2.9 | signal |
| 145 | Product Physical Issue | 11 | 2.8 | 2.8 | signal |
| 146 | Back Disorder | 9 | 2.8 | 2.8 | signal |
| 147 | Product Prescribing Error | 13 | 2.8 | 2.8 | signal |
| 148 | Hepatitis | 14 | 2.8 | 2.8 | signal |
| 149 | Nasopharyngitis | 101 | 2.8 | 2.8 | signal |
| 150 | Swelling | 51 | 2.8 | 2.8 | signal |
| 151 | Injection Site Swelling | 41 | 2.8 | 2.8 | signal |
| 152 | Abdominal Pain Upper | 110 | 2.7 | 2.8 | signal |
| 153 | Hepatic Cirrhosis | 10 | 2.7 | 2.7 | signal |
| 154 | Urinary Tract Infection | 90 | 2.7 | 2.8 | signal |
| 155 | Rhinorrhoea | 34 | 2.7 | 2.7 | signal |
| 156 | Hypoaesthesia | 79 | 2.7 | 2.7 | signal |
| 157 | Hunger | 7 | 2.7 | 2.7 | signal |
| 158 | Inappropriate Schedule Of Product Administration | 92 | 2.7 | 2.7 | signal |
| 159 | Arthropathy | 29 | 2.7 | 2.7 | signal |
| 160 | Hypoglycaemia | 25 | 2.6 | 2.6 | signal |
| 161 | Fatigue | 385 | 2.5 | 2.7 | signal |
| 162 | Thyroid Cancer | 6 | 2.5 | 2.5 | signal |
| 163 | Weight Increased | 110 | 2.5 | 2.6 | signal |
| 164 | Chromaturia | 11 | 2.5 | 2.5 | signal |
| 165 | Product Preparation Error | 10 | 2.5 | 2.5 | signal |
| 166 | Brain Fog | 7 | 2.5 | 2.5 | signal |
| 167 | Liver Function Test Abnormal | 14 | 2.5 | 2.5 | signal |
| 168 | Device Mechanical Issue | 6 | 2.4 | 2.4 | no signal |
| 169 | Oropharyngeal Pain | 43 | 2.4 | 2.4 | signal |
| 170 | Pain In Jaw | 13 | 2.3 | 2.4 | signal |
| 171 | Gastrointestinal Pain | 5 | 2.3 | 2.3 | no signal |
| 172 | Malaise | 200 | 2.3 | 2.4 | signal |
| 173 | Upper Limb Fracture | 9 | 2.3 | 2.3 | signal |
| 174 | Rash Papular | 10 | 2.3 | 2.3 | signal |
| 175 | Therapeutic Response Unexpected | 20 | 2.3 | 2.3 | signal |
| 176 | Injection Site Pruritus | 29 | 2.2 | 2.2 | signal |
| 177 | Diverticulitis | 12 | 2.2 | 2.2 | signal |
| 178 | Hepatic Function Abnormal | 16 | 2.2 | 2.2 | signal |
| 179 | Carpal Tunnel Syndrome | 6 | 2.2 | 2.2 | no signal |
| 180 | Nasal Congestion | 25 | 2.2 | 2.2 | signal |
| 181 | Feeling Abnormal | 102 | 2.2 | 2.2 | signal |
| 182 | Depressed Mood | 22 | 2.1 | 2.1 | signal |
| 183 | Transient Ischaemic Attack | 14 | 2.1 | 2.1 | signal |
| 184 | Covid-19 | 72 | 2.1 | 2.1 | signal |
| 185 | Product Administration Error | 8 | 2.1 | 2.1 | no signal |
| 186 | Exposure Via Skin Contact | 9 | 2.0 | 2.0 | no signal |
| 187 | Injection Site Rash | 12 | 2.0 | 2.0 | signal |
| 188 | Injection Site Irritation | 5 | 2.0 | 2.0 | no signal |
| 189 | Erectile Dysfunction | 10 | 2.0 | 2.0 | no signal |
| 190 | Hip Fracture | 12 | 1.9 | 1.9 | no signal |
| 191 | Device Issue | 32 | 1.9 | 1.9 | no signal |
| 192 | Product Packaging Quantity Issue | 4 | 1.9 | 1.9 | no signal |
| 193 | Hernia | 7 | 1.9 | 1.9 | no signal |
| 194 | Device Difficult To Use | 24 | 1.9 | 1.9 | no signal |
| 195 | Drug Effect Less Than Expected | 5 | 1.8 | 1.8 | no signal |
| 196 | Incorrect Dose Administered By Device | 9 | 1.8 | 1.8 | no signal |
| 197 | Drug Effect Incomplete | 13 | 1.8 | 1.8 | no signal |
| 198 | Gastric Disorder | 12 | 1.8 | 1.8 | no signal |
| 199 | Spinal Operation | 4 | 1.7 | 1.7 | no signal |
| 200 | Blood Thyroid Stimulating Hormone Increased | 3 | 1.7 | 1.7 | no signal |
| 201 | Nervousness | 17 | 1.7 | 1.7 | no signal |
| 202 | Emotional Disorder | 10 | 1.7 | 1.7 | no signal |
| 203 | Blindness | 13 | 1.6 | 1.6 | no signal |
| 204 | Affect Lability | 3 | 1.6 | 1.6 | no signal |
| 205 | Knee Operation | 3 | 1.6 | 1.6 | no signal |
| 206 | Decreased Immune Responsiveness | 3 | 1.6 | 1.6 | no signal |
| 207 | Hypoacusis | 13 | 1.6 | 1.6 | no signal |
| 208 | Influenza Like Illness | 25 | 1.5 | 1.6 | no signal |
| 209 | Cerebrovascular Accident | 51 | 1.5 | 1.5 | no signal |
| 210 | Injury Associated With Device | 6 | 1.5 | 1.5 | no signal |
| 211 | Ovarian Cyst | 3 | 1.5 | 1.5 | no signal |
| 212 | Injection Site Erythema | 36 | 1.5 | 1.5 | no signal |
| 213 | Knee Arthroplasty | 6 | 1.5 | 1.5 | no signal |
| 214 | Cardiac Disorder | 27 | 1.5 | 1.5 | no signal |
| 215 | Breast Pain | 3 | 1.4 | 1.4 | no signal |
| 216 | Hepatocellular Injury | 4 | 1.4 | 1.4 | no signal |
| 217 | Product Administered At Inappropriate Site | 5 | 1.4 | 1.4 | no signal |
| 218 | Device Malfunction | 18 | 1.4 | 1.4 | no signal |
| 219 | Menorrhagia | 5 | 1.3 | 1.3 | no signal |
| 220 | Incorrect Route Of Drug Administration | 9 | 1.3 | 1.3 | no signal |
| 221 | Product Quality Issue | 33 | 1.3 | 1.3 | no signal |
| 222 | Injection Site Warmth | 5 | 1.2 | 1.2 | no signal |
| 223 | Amenorrhoea | 4 | 1.2 | 1.2 | no signal |
| 224 | Diabetic Ketoacidosis | 5 | 1.1 | 1.1 | no signal |
| 225 | Inappropriate Schedule Of Drug Administration | 15 | 1.1 | 1.1 | no signal |
| 226 | Incorrect Dose Administered | 45 | 1.0 | 1.0 | no signal |
| 227 | Breast Cancer | 17 | 0.9 | 0.9 | no signal |
| 228 | Pancreatic Carcinoma | 5 | 0.9 | 0.9 | no signal |
| 229 | Abortion Spontaneous | 6 | 0.8 | 0.8 | no signal |
| 230 | Circumstance Or Information Capable Of Leading To Medication Error | 5 | 0.8 | 0.8 | no signal |
| 231 | Injection Site Urticaria | 3 | 0.6 | 0.6 | no signal |
| 232 | Device Use Error | 4 | 0.6 | 0.6 | no signal |
| 233 | Gastric Cancer | 3 | 0.6 | 0.6 | no signal |
| 234 | Product Storage Error | 9 | 0.5 | 0.5 | no signal |
| 235 | Prostate Cancer | 8 | 0.5 | 0.5 | no signal |
| 236 | Accidental Exposure To Product | 9 | 0.5 | 0.5 | no signal |
| 237 | Renal Cancer | 4 | 0.4 | 0.4 | no signal |